Estrella Immunopharma, Inc. (ESLAW) › EPS (Diluted)Estrella Immunopharma, Inc. (ESLAW) — EPS (Diluted)Annual figures by fiscal year, from SEC filings.2023: $-36.352024: $-0.272025: $-0.35$-0.352023EPS (Diluted) (USD/shares)2025Fiscal YearEPS (Diluted)Change YoY2025$-0.35-29.6%2024$-0.27+99.3%2023$-36.35—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeTotal AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share